Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
Status:
Withdrawn
Trial end date:
2022-03-10
Target enrollment:
Participant gender:
Summary
The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of
onset immediately after an upper respiratory viral illness, assigned to three distinct study
arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm
will receive a paper hand-out about post-viral anosmia with instructions to smell common
household items (current care) and act as a control group. The second group will receive an
essential oil retraining kit, whereas the third group will receive the same olfactory
training kit and a prescription to use budesonide with the nasal irrigations. Olfactory
scores will be tested at the enrollment, 3 months and at 6 months.